March 15, 2016
ITOC3 is the premier European conference for scientific exchange, translational research and networking within cancer immunotherapy, bringing together preclinical and clinical scientists, academia and clinical investigators.
Crown Bioscience supports research in immunotherapy with a range of platforms, with either murine or human immunity. Our immunotherapy resources include syngenic (bioluminescent and metastatic) models, GEMM, MuPrime™ (the murine version of HuPrime® which is the world’s largest collection of well-characterized and validated Patient-Derived Xenograft models), HuMice™ (humanized mice produced through inoculating human hematopoietic cells into immunocompromised mice), and MiXeno™ (creating transient human immunity by mixing human peripheral blood mononucleated cells with xenograft models).
We also support preclinical drug development through the use of our in vivo grade human and mouse isotype control antibodies.
If you want to know how CrownBio can help accelerate your drug discovery program contact Dr. Sebastian Dempe, Business Development Director, Central Europe to arrange a meeting at ITOC3 or send us an email.